Skip to main content

Table 1 Summary of basic clinical and FAP IHC information of the cohort of 15 malignant gliomas

From: Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

Sample Number Pathology Primary vsersu recurrent IDH1 Status Perivascular FAP Parenchymal FAP
MGG7 GBM Primary Wild type ++
MGG8 GBM Primary Wild type ++
MGG63 GBM Recurrent Wild type +
MGG65 GBM Primary Wild type ++
MGG66 GBM Primary Wild type +
MGG67 GBM Primary Wild type +
MGG81 GBM Primary Mutant +
MGG90 GBM Primary Wild type ++
MGG100 GBM Primary Wild type +
MGG125 GBM Primary Wild type + +
MGG153 GBM Primary Wild type + +
MGG162 AA Primary Mutant +
MGG168 GBM Recurrent Wild type +
MGG169 GBM Primary Wild type +
MGG225 GBM Primary Wild type + +
  1. GBM, glioblastoma; AA, anaplastic astrocytoma; −, negative, +, 2% or less; ++, 2–10%